Dharini Rawal

Title: The Innovations of Dharini Rawal

Introduction

Dharini Rawal is an accomplished inventor based in Washington Township, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of human insulin-like growth factor binding proteins. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to advancing healthcare solutions.

Latest Patents

Dharini Rawal holds 1 patent for her invention titled "Non-recombinant human insulin-like growth factor binding protein concentrate." This patent describes a human insulin-like growth factor (IGF) binding protein stock solution and a method for its production. The solution includes a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium, with concentrations ranging from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. Additionally, her invention includes a kit with a set of calibrators for nr-IGFBP-3, which features the protein in various concentrations.

Career Highlights

Dharini Rawal is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to innovate and contribute to the field of diagnostics. Her role at Siemens allows her to collaborate with other talented professionals and work on cutting-edge technologies that can improve patient outcomes.

Collaborations

Dharini has worked alongside notable colleagues such as Omar Quraishi and Spencer Lin. These collaborations have further enriched her experience and have led to advancements in their shared projects.

Conclusion

Dharini Rawal exemplifies the spirit of innovation in the biotechnology sector. Her contributions, particularly in the development of human insulin-like growth factor binding proteins, highlight her commitment to improving healthcare solutions. Her work continues to inspire future advancements in the field.